$0.96
-0.02 (-2.28%)
Open$0.98
Previous Close$0.99
Day High$1.00
Day Low$0.95
52W High$3.09
52W Low$1.35
Volume—
Avg Volume163.7K
Market Cap188.33M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+4,012.2% upside
Current
$0.96
$0.96
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 364.10M | 300.56M | 81.33M |
| Net Income | -34,777,682 | -25,837,802 | 15.27M |
| Profit Margin | -9.6% | -9.1% | 18.8% |
| EBITDA | -19,926,769 | -15,626,903 | 21.57M |
| Free Cash Flow | — | — | 16.42M |
| Rev Growth | +21.1% | +21.1% | -3.5% |
| Debt/Equity | 0.22 | 0.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |